Quarterly report pursuant to Section 13 or 15(d)

Stock-based Compensation (Tables)

v3.23.3
Stock-based Compensation (Tables)
 9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-based Compensation Expense

We recorded stock-based compensation expense for the three and nine months ended September 30, 2023 and 2022 as follows:

  

    2023     2022     2023     2022  
    Three Months Ended
September 30,		     Nine Months Ended
September 30,		  
    2023     2022     2023     2022  
Research and development   $ 76,626     $ 1,067,613     $ 286,152     $ 1,945,113  
General and administrative     66,268       2,146,202       517,369       4,106,968  
Total   $ 142,894     $ 3,213,815     $ 803,521     $ 6,052,081  
Schedule of Restricted Stock Awards (“RSAs”) Activity

Activity with respect to our Restricted Stock Awards (RSAs) during the nine months ended September 30, 2023 was as follows:

 

    Number of
shares		     Weighted-
average
grant-date
fair
value per
share		  
Outstanding at January 1, 2023     61,888     $ 4.72  
Granted     215,000       0.73  
Forfeited     (25,000 )     6.65  
Cancelled     (26,118 )     1.72  
Issued     (150,770 )     1.35  
                 
Outstanding and unvested at September 30, 2023     75,000     $ 0.46  
Schedule of Restricted Stock Units (“RSUs”) Activity

Activity with respect to our Restricted Stock Units (“RSUs”) during the nine months ended September 30, 2023 was as follows:

 

    Number of
shares		     Weighted-
average
grant-date
fair
value per
share		  
Outstanding at January 1, 2023     2,713,977     $ 3.69  
Granted     2,273,328       0.72  
Forfeited     (144,478 )     1.48  
Cancelled     (335,960 )     3.57  
Outstanding at September 30, 2023     4,506,867       2.30  
Vested and unissued     2,291,923       3.58  
                 
Unvested at September 30, 2023     2,214,944     $ 0.97